Objective: To explore this potential effect of intralesional vitamin D in treatment of cutaneous viral warts. Methodology: All the patients with cutaneous viral warts coming to the Department of Dermatology, Venereology and Leprology at our tertiary care hospital was included in the study from October 2017 to May 2019. Total 35 patients were included. Clinical response was documented by recording the decrease in number and size of viral warty lesions at each visit i.e. at 2 weekly intervals for 4 sessions and follow up and examination of patient was done 3 months after last injection Result: Most common type of viral warts were verruca plana (45.7%) followed by filiform viral warts (22.9%) and verruca vulgaris (20%). Almost half of the patients have complete response (51.4%) than 37.1% have partial response and only 11.4% did not have any improvement Conclusion: Intralesional Vitamin D3 injection is an innovative approach for the treatment of viral warts.